John Land, DPM
Podiatrist · Dalton, GANPI 1568548220
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,306 of the $3,506 with a category attached, or 65.8%. 10 manufacturers reported payments, led by Organogenesis Inc. at 41.1% of the total. Reporting peaked in 2021 at $1,245 and has fallen 97.9% since, to $26 in 2025.
Across 84 payments — averaging $41.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$1K
- Alpha Orthopedic Systems$1K
- Smith+Nephew$391
- Linvatec Corporation$182
- Osiris Therapeutics Inc.$83
- AbbVie$81
- plus $130 from 4 others
What the payments were for
- Food & beverage$2,30666%
- Education$1,20034%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 56 | $1,440 |
| Alpha Orthopedic Systems | 1 | $1,200 |
| Smith+Nephew | 12 | $391 |
| Linvatec Corporation | 3 | $182 |
| Osiris Therapeutics Inc. | 1 | $83 |
| AbbVie(2 entities) | 6 | $81 |
| Polymedics Innovations Inc. | 1 | $53 |
| Bioventus LLC | 2 | $48 |
| Melinta Therapeutics, LLC | 1 | $17 |
| Acumed LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$333
- PuraPly$226
- BioBrace 23mm$159
How this compares
$3,506 in reported general payments places this provider in the 70th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 222 | $2,727 |
| Duloxetine Hcl | 175 | $2,303 |
| Terbinafine Hcl | 224 | $2,290 |
| Pregabalin | 66 | $1,950 |
| Doxycycline Hyclate | 155 | $1,622 |
| Ropinirole Hcl | 76 | $1,261 |
| Fluconazole | 37 | $1,154 |
| Mupirocin | 168 | $1,113 |
| Fluorouracil | 14 | $838 |
| Ciprofloxacin Hcl | 85 | $794 |
| Allopurinol | 58 | $703 |
| Colchicine | 27 | $639 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 46 | $554 |
| Celecoxib | 15 | $447 |
| Meloxicam | 52 | $227 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Dalton
- Trey EdwardsDalton$11K
- Allen RaphaelSmyrna$324K
- Ira KrausFort Oglethorpe$223K
- Stephen BarrettMarietta$82K
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Ryan FitzgeraldCanton$43K
- Margo JimenezAtlanta$19K
- Samantha MinerSmyrna$17K
- Robson SpinolaJesup$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.